Stay updated with breaking news from Rigel Pharmaceutical. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL – Get Rating) – Equities research analysts at B. Riley increased their FY2023 earnings per share estimates for shares of Rigel Pharmaceuticals in a research report issued to clients and investors on Wednesday, May 3rd. B. Riley analyst K. Patel now forecasts that the biotechnology company will earn ($0.26) per share […]
Organon & Co. (NYSE:OGN – Get Rating) and Rigel Pharmaceuticals (NASDAQ:RIGL – Get Rating) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, earnings, risk, institutional ownership, profitability and dividends. Profitability This table compares Organon & Co. and Rigel […]
Purple Biotech (NASDAQ:PPBT – Get Rating) and Rigel Pharmaceuticals (NASDAQ:RIGL – Get Rating) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, valuation, risk, dividends, profitability and analyst recommendations. Profitability This table compares Purple Biotech and Rigel Pharmaceuticals’ […]
Rigel Pharmaceuticals (NASDAQ:RIGL – Get Rating) was downgraded by equities research analysts at Cantor Fitzgerald from an “overweight” rating to a “neutral” rating in a note issued to investors on Wednesday, Briefing.com reports. They presently have a $1.00 price objective on the biotechnology company’s stock, down from their prior price objective of $6.00. Cantor Fitzgerald’s […]
Equities research analysts expect Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL – Get Rating) to post sales of $22.78 million for the current fiscal quarter, Zacks reports. Four analysts have provided estimates for Rigel Pharmaceuticals’ earnings. The lowest sales estimate is $20.64 million and the highest is $24.04 million. Rigel Pharmaceuticals reported sales of $26.27 million in the […]